台湾大学林峰辉教授报告-清洁能源实验室系列学术报告(四十三)
2015年8月31日上午9:00,台湾大学林峰辉教授在物理所M236做关于Materials Technology in Medicine Idea Brewing and Research Design的报告。
讲座相关:
Abstract:
Double-chamber bioreactor, that could co-culture two kinds of cells in one device to stimulate each other for tissue growth without additional growth factors, has been developed for the skin tissue engineering where dermal fibroblast and keratinocyte were seeded on to culture together for skin equivalent tissue to be growth in vitro.
The tricopolymer, that contained three major components of extacellular matrix (ECM), hyaluroinc acid, chondroitin sulfate and collagen, has been prepared as a scaffold for osteochondral graft tissue engineering. The material is to simulate the ECM of articular cartilage that to “cheat” cell something like at home to proliferate in proper way, to differentiate toward desire pathway, and eventually to grow up into full-blown tissue.
报告人介绍:
Dr. Feng-Huei Lin was born in 1957 in Taiwan. He obtained his BS degree in Department of Earth Sciences, National Cheng Kung University (NCKU), Taiwan, in 1980. After served in army for 2 years, he was invited to be a teaching assistant in Department of ES, NCKU, in 1982. In 1983, he joined the Functional Ceramics Lab in Institute of Materials Sciences and Engineering, NCKU, Taiwan. In early 1990, He was recruited as an associate professor in Centre for Biomedical Engineering, College of Medicine, National Taiwan University (NTU); where he started his academic career. In 1997, he promoted to the full professor. He organized to setup the institute of biomedical engineering in NTU and served as acting director in the institute during 1997-1999. He was invited to be the first Engineering background director in Department of Biomedical Engineering, NTU-hospital (2003-2005). In 2005-2008, he back institute of biomedical engineering, NTU, as director. During 2006-2009, National Science Council, Taiwan, asked his help to be the Convenor of Biomedical Division to allocate the budget and to make the future planning in the next 10 years. In 2008-2012, he temporarily transferred to Biomedical Engineering Division, National Health Research Institute, as director and took in charge of Development of Biomaterials and Tissue Engineering. Now, he is the distinguished professor in NTU, Chair professor in National Taipei University of Technology, Executive editor of Journal of Biomedical Engineering (SCI) and International Fellow of International College of Biomaterials Sciences and Engineering. Since 1990, Dr Lin has published over 350 SCI papers, joined 9 book chapters, awarded 47 patents and transferred 14 technologies to industry to be product. His research is in scaffold for tissue engineering, nano-technology for drug and gene delivery, bio-nano-science for cancer hyperthermia, biomaterials for stem cell research, and hydrogel for vitreous body substitute.